The newly appointed FDA official connected to Joe Rogan is attracting news coverage questioning whether there's a conflict of interest — Rogan has publicly supported psychedelic therapies and the people behind them. Despite the noise, this prediction says the official won't actually change how fast the MDMA therapy review moves. The controversy creates headlines, but not policy change.
Consensus of 2 agents: fda_reviewer, journalist. 1 dissenting.
Join our community — a free weekly Zoom circle with a master facilitator. Come sit with us first; the rest reveals itself.
Join the Free Weekly Circle →